Efficacy of tranexamic acid on intra-operative blood loss and ovarian reserve during laparoscopic cystectomy of endometriotic cyst

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20190424002

Enrollment

Unknown

Registered

2019-04-24

Start date

2019-05-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian endometriotic cyst Endometrioma&#44

Interventions

Tranexamic acid 250 mg/amp for 1 amp intravenous during laparoscopic cystectomy,No medication prescribed

Sham Comparator Drug,No Intervention No treatment

Tranexamic acid,Control

Eligibility

Sex/Gender

All

Age

0 Years to 0 Years

Inclusion criteria

Inclusion criteria: 1)healthy women age 19-45 years 2) diagnose an endometrioma size at least 3 cm in diameter but less than 10 cm and scheduled for unilateral laparoscopic cystectomy 3) No history of oral hormone within 3 months and no treatment history of à¸£à¸±à¸š depot-medroxyprogesterone acetate (DMPA) or GnRH agonist 9 months before surgery 4) no contraindication for Ethinyl estradiol à¹à¸¥à¸°Desogestrel 5) no desire for a child

Exclusion criteria

Exclusion criteria: 1. women in menopause period 2. Pregnant women 3. Suspected ovarian cancer 4. Endometrioma larger than 10 cm in diameter 5. Previous history of adnexal or ovarian surgery

Design outcomes

Primary

Measure	Time frame
Serum anti-mullerian hormone 0, 3 months serum level	—

Secondary

Measure	Time frame
Intraoperative blood loss 0 (during surgery) weigh	—

Countries

Thailand

Contacts

Public ContactAreepan Sophonsritsuk

Ramathibodi Hospital

areepan.sop@mahidol.ac.th0809096531

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Efficacy of tranexamic acid on intra&#45;operative blood loss and ovarian reserve during laparoscopic cystectomy of endometriotic cyst